Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2746366010 | Nasal form dihydroergotamine mesylate (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2771065014 | Nasal form dihydroergotamine mesylate | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3487654011 | Product containing dihydroergotamine mesylate in nasal dosage form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3496216013 | Product containing dihydroergotamine mesylate in nasal dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3496217016 | Dihydroergotamine mesylate in nasal dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dihydroergotamine mesylate in nasal dosage form | Is a | Product containing dihydroergotamine mesylate | false | Inferred relationship | Some | ||
| Product containing dihydroergotamine mesylate in nasal dosage form | Is a | Product manufactured as nasal dose form (product) | false | Inferred relationship | Some | ||
| Product containing dihydroergotamine mesylate in nasal dosage form | Has active ingredient | Dihydroergotamine mesilate | false | Inferred relationship | Some | ||
| Product containing dihydroergotamine mesylate in nasal dosage form | Has manufactured dose form | Nasal dose form (dose form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dihydroergotamine mesylate 4mg/1mL nasal spray | Is a | False | Product containing dihydroergotamine mesylate in nasal dosage form | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR